The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis
Open accessAbstract
characterized by acute respiratory distress syndrome (ARDS), systemic inflammatory response syndrome (SIRS), and / or multiple organ failure (MOF).5 Considering the current virtually unstoppable trajectory of SARS -CoV -2, 6 together with the high prevalence of hypertension (an estimated 26% of the world population), 7 we may predict that the combination of these 2 conditions will soon pose overwhelming clinical, societal, and economic burdens on humans.8 However, whereas the media widely reported that hypertension increases the risk of severe COVID -19, some early reports found no association between hypertension and disease severity.9,10 Therefore, this article aims to examine the strength of a possible clinical interplay between hypertension and COVID -19 in order to learn whether hypertensive patients infected with SARS -CoV -2 may be at particularly increased risk of the worst clinical outcomes. IntroductIonThe outbreak of coronavirus disease 2019 (COVID -19) has spread across the world, affecting over 500 000 people and causing more than 25 000 deaths to date. 1 This infectious disease is caused by the severe acute respiratory syndrome coronavirus 2 (SARS -CoV -2), 2 which enters cells through the angiotensin -converting enzyme 2 (ACE2) receptor and, therefore, human -to -human transmission occurs.3 The function of this enzyme is to catalyze the conversion of angiotensin II to angiotensin 1-7, a peptide which opposes the proinflammatory, pro -oxidative, vasoconstrictive, and fibrotic properties of angiotensin II. 4 Due to the interplay between SARS -CoV -2 and ACE2, it was suggested that hypertension may be involved in the pathogenesis of COVID -19 either by playing a direct role as a pre -existing clinical predictor of disease severity or by contributing to deterioration late in the course of the disease orIGInAL ArtIcLE Hypertension in patients with coronavirus disease 2019 (COVID -19)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Henry, B. M., de Oliveira, M. H. S., Benoit, S., Plebani, M., & Lippi, G. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0369 · Cited by 1,964
Self-citationFerrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565
Liu, W., Tao, Z.-W., Wang, L., Yuan, M.-L., Liu, K., Zhou, L., Wei, S., Deng, Y., Liu, J., Liu, H.-G., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000775 · Cited by 1,104
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063
Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing
Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y., Lang, C., Huang, D., Sun, Q., Xiong, Y., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25783 · Cited by 982
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898
Risk factors for community-acquired pneumonia in adults in Europe: a literature review
Torres, A., Peetermans, W. E., Viegi, G., & Blasi, F. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-204282 · Cited by 839
Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection
Henry, B. M., & Lippi, G. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02451-9 · Cited by 547
Self-citationClinical Characteristics of Covid-19 in China
(2020) · New England Journal of Medicine · doi:10.1056/nejmc2005203 · Cited by 475
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06028-z · Cited by 421
SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
Kuster, G. M., Pfister, O., Burkard, T., Zhou, Q., Twerenbold, R., Haaf, P., Widmer, A. F., & Osswald, S. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa235 · Cited by 395
Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)
Lippi, G., & Henry, B. M. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.105941 · Cited by 380
Self-citationChen, C., Chen, C., Yan, J. T., Zhou, N., Zhao, J. P., & Wang, D. W. (2020) · PubMed · doi:10.3760/cma.j.cn112148-20200225-00123 · Cited by 283
Klimas, J., Olvedy, M., Ochodnicka‐Mackovicova, K., Kružliak, P., Čačányiová, S., Kristek, F., Křenek, P., & Ochodnický, P. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12573 · Cited by 127
The systemic inflammatory response syndrome
Weigand, M. A., Hörner, C., Bardenheuer, H. J., & Bouchon, A. (2004) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2003.12.005 · Cited by 122
Blood pressure variability and multiple organ damage in primary hypertension
Leoncini, G., Viazzi, F. C., Storace, G., Deferrari, G., & Pontremoli, R. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.45 · Cited by 94
Azoulay, É., Lemiale, V., Mourvillier, B., Garrouste-Orgeas, M., Schwebel, C., Ruckly, S., Argaud, L., Cohen, Y., Souweine, B., Papazian, L., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5209-6 · Cited by 94
Chalmers, J. D., Singanayagam, A., & HILL, A. T. (2008) · Thorax · doi:10.1136/thx.2008.095562 · Cited by 90
Risk factors for outcomes of acute respiratory distress syndrome patients: a retrospective study
Dai, Q., Wang, S., Liu, R., Wang, H., Zheng, J., & Yu, K. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.02.84 · Cited by 58
Cited by
Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis
Tian, W., Jiang, W., Yao, J., Nicholson, C. J., Li, R. H., Sigurslid, H. H., Wooster, L., Rotter, J. I., Guo, X., & Malhotra, R. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26050 · Cited by 640
Shi, Q., Zhang, X., Jiang, F., Zhang, X., Hu, N., Bimu, C., Feng, J., Yan, S., Guan, Y., Xu, D., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0598 · Cited by 417
Zhou, Y., Yang, Q., Chi, J., Dong, B., Lv, W., Shen, L., & Wang, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.07.029 · Cited by 407
Wang, X., Fang, X., Cai, Z., Wu, X., Gao, X., Min, J., & Wang, F. (2020) · Research · doi:10.34133/2020/2402961 · Cited by 387
BULUT, C., & KATO, Y. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2004-172 · Cited by 321
Metadata
- Authors
- Lippi, G., Wong, J., & Henry, B. M.
- Venue
- Polish Archives of Internal Medicine
- Publisher
- Medycyna Praktyczna
- Published
- 2020-03-31
- Volume
- 130
- Issue
- 4
- Pages
- 304-309
- ISSN
- 0032-3772 (ISSN-L)
- 1897-9483
- OpenAlex
- W3013535542
- Cited by
- 421
- References
- 25
- FWCI
- 11.80
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.